Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Hangzhou Valgen Medtech Co., Ltd. is a company headquartered in Hangzhou, China, that develops and manufactures novel mitral valve repair systems. The firm was founded in 2015. Ting Chao Zhang is currently the CEO of the company.

Jenscare Scientific Co., Ltd. is a holding company, which engages in the development and sale of transcatheter aortic valve systems. Its products include transcatheter prosthetic three tricuspid valve system and transcatheter aortic valve system. The company was founded on November 8, 2011 and is headquartered in Ningbo, China.

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chest incision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass. Founded in 2007 and is based in St. Louis Park, MN.

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

HighLife is a company focused on Transcatheter Mitral Valve Replacement (TMVR). The technology is intended for treatment of patients suffering from mitral valve regurgitation and is currently in a stage of clinical evaluation. The company was co-founded in 2010 by Mr. Georg Börtlein, President & CEO. The intent is to provide a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. Ease and safety of use and delivery are key elements of the HighLife technology.

Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China.

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Cook, Inc. develops healthcare devices. The company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety as well as improve clinical outcomes in the fields of aortic intervention, interventional cardiology, critical care medicine, gastroenterology, radiology, peripheral vascular, bone access & oncology, surgery and soft tissue repair, urology, and assisted reproductive technology, gynecology as well as high-risk obstetrics. The company is located in Bloomington, IN.

Medtronic Vascular designs and develops technologies for coronary, peripheral, and neurovascular indications. The company’s products include S7 Zipper MX Coronary Stent System, Clo-Sur PAD Nonwoven Hydrophilic Wound Dressing, Launcher Coronary Guide Catheter, and Stormer Over-the-Wire Balloon Dilatation Catheter. The company also offers Bridge Assurant Balloon-Expandable Stent Delivery System, GuardWire Plus Temporary Occlusion and Aspiration System, and S660 Coronary Stent. Medtronic Vascular was incorporated in 1991 and is based in Santa Rosa, California. As of January 29, 1999, Medtronic Vascular operates as a subsidiary of Medtronic.

Jinshi Biotechnology (Changsu) Co., Ltd. (doing business as Kingstronbio) is a Chinese company located in Changsu specializing in surgical and medical instruments and apparatus. It was founded in 2012 by Sheng Ping Zhong, he has been the CEO since that date.

Part of Abbott Laboratories, St. Jude Medical, Cardiology Division, Inc. is a company headquartered in St. Paul, MN. The firm develops and commercializes minimally invasive cardiovascular and neurovascular medical devices. It was founded by Paul R. Buckman. Lisa D. Earnhardt is currently the CEO of the company.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Part of LifeTech Scientific Corp., Lifetech Scientific (Shenzhen) Co. Ltd. is a Chinese company located in Shenzhen that manufactures medical devices. On July 06, 2004 ATC Technology Corp. (Arizona) acquired Lifetech Scientific (Shenzhen) Co. Ltd.